Reputation

What Happens When Multinationals Appear in Reporting on Activist Assassinations? High-Profile Media Has Bite

A new report finds that being linked to human rights abuses—merely appearing in reporting around high-profile events—can significantly influence a company’s stock...

Regulators as Validators

Special interest groups can use their influence over regulation to water down not just potential legal sanctions but also potential reputational sanctions. What deters corporate...

Who Killed Corporate Reputation?

Regulation and reputation are not independent of each other. Regulation can substitute, crowd out, or even implement the power of reputational concerns. A better understanding...

Corporate Governance Externalities: How Directors’ Reputational Concerns Shape Governance of Other Firms

A new paper by Wharton’s Doron Levit and Carroll’s Nadya Malenko fleshes out the role that reputation plays in shaping the structure and effectiveness of...

LATEST NEWS

Female Academics Are Disproportionately Affected By Covid-19 Disruptions In Childcare

A new paper finds that academics who are parents to young children, and especially mothers, have lost a significant amount of research...

Rethinking Competition: From Market Failures to Ecosystem Failures

Despite the overwhelming importance of digital platforms, and the chatter around their recent rise, our understanding of digital ecosystems is still limited....

A Famed Economist’s Public Company U-Turn

Michael Jensen, a leading late 20th century economist, pivoted from praising public companies in the 1970s to assailing public company governance in...

Chinese Antitrust 2.0: Why Is China Going After Its Big Tech?

In an interview with ProMarket, Angela Huyue Zhang, author of a new book Chinese Antitrust Exceptionalism, discusses the motivations behind the recent...

Preventing Drug Shortages and Saving Lives: The Role of Quality and Reliability Standards

Prescription drug shortages have become more common in recent years, interrupting usual medical care and increasing patient risk and system costs, but...